The report covers the present scenario and the growth prospects of the global migraine drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that will be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
Global Migraine Drugs Market 2016-2020 is a new research report added to Sandlerresearch.org.
Complete report available @ www.sandlerresearch.org/global-…-2020.html
The analysts forecast global migraine drugs market to grow at a CAGR of 4.56% during the period 2016-2020. A migraine is characterized by repeated attacks of a severe headache, nausea, vomiting, and extreme sensitivity to light and sound.
Women are more prone to the disease compared to men owing to the fluctuating levels of hormones in their bodies. Therapeutic agents such as anti-inflammatory painkillers, antimigraine drugs, antisickness medicines, and triptans are used for the treatment of the disease.
Get Report @ www.sandlerresearch.org/discoun…name=54165 .
The report, Global Migraine Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
The report also includes a discussion of the key vendors operating in this market.
Key vendors
Allergan
Endo International
GlaxoSmithKline
Impax
Pfizer
Other prominent vendors
Abbott
Aegis Therapeutics
Aeriel BioPharma
Alder Biopharmaceuticals
Amgen
Astellas
AstraZeneca
Bayer
CoLucid
Dr. Reddy’s Laboratories
Eisai
Eli Lilly
Ethypharm
IntelGenx
Johnson & Johnson
Klaria
Kowa Pharmaceuticals America
Luitpold Pharmaceuticals
Meda
Merck
OptiNose
Pfizer
Pozen
Raptor
RedHill
SUDA
Teva
TG Therapeutics
NValeant
Winston Pharmaceuticals
Zogenix
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Percentage of migraine sufferers worldwide by gender
Exhibit 03: Global migraine drugs market: Pipeline portfolio
Exhibit 04: Global migraine drugs market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Preventative medications based on efficacy of drugs
Exhibit 07: Medications used based on severity of migraines
Exhibit 08: Percentage share of preventative and abortive migraine medications in US 2015
Exhibit 09: Segmentation of global migraine drugs market by therapeutic class 2015
Exhibit 10: Market share of triptans by ROA 2015
Exhibit 11: Global migraine drugs market by geography 2015
Exhibit 12: Global migraine drugs market by geography 2015-2020 ($ millions)
Exhibit 13: Migraine drugs market in Americas 2015-2020 ($ billions) and more..
For more information:
News From
Sandler Research Category: Industry Reports & Market Analysis Profile: Sandlerresearch.org is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.
